New cancer drug KK2260 enters first human trials
NCT ID NCT06248411
First seen Feb 22, 2026 · Last updated Apr 28, 2026 · Updated 9 times
Summary
This study is the first time the experimental drug KK2260 is being tested in people. It aims to find a safe dose and check for side effects in about 189 adults with advanced or metastatic solid tumors (cancers that have spread). The trial includes people with esophageal or head and neck cancers. Participants must have tried standard treatments without success or be unable to take them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aichi Cancer Center Hospital
RECRUITINGNagoya, Aichi-ken, 464-8681, Japan
-
Hiroshima University Hospital
NOT_YET_RECRUITINGHiroshima, Hiroshima, 734-8551, Japan
-
Kanagawa Cancer Center
RECRUITINGYokohama, Kanagawa, 241-8515, Japan
-
Kobe University Hospital
RECRUITINGKobe, Hyōgo, 650-0017, Japan
-
Kumamoto University Hospital
NOT_YET_RECRUITINGKumamoto, Kumamoto, 860-8556, Japan
-
Kyushu Cancer Center
RECRUITINGFukuoka, 811-1347, Japan
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East
RECRUITINGKashiwa, Chiba, 277-8577, Japan
-
Osaka International Cancer Institute
RECRUITINGOsaka, 540-0008, Japan
-
Saitama Cancer Center
RECRUITINGShinden, Saitama, 362-0806, Japan
-
Shizuoka Cancer Center
RECRUITINGNagaizumi-cho, Shizuoka, 411-8777, Japan
-
The Cancer Institute Hospital of JFCR
RECRUITINGKoto-ku, Tokyo, 135-8550, Japan
-
Tohoku University Hospital
NOT_YET_RECRUITINGSendai, Miyagi, 980-8574, Japan
Conditions
Explore the condition pages connected to this study.